SCYX
Scynexis Inc

10,076
Mkt Cap
$31.47M
Volume
163,038.00
52W High
$1.31
52W Low
$0.565
PE Ratio
-1.40
SCYX Fundamentals
Price
$0.75
Prev Close
$0.705
Open
$0.719
50D MA
$0.7016
Beta
1.04
Avg. Volume
492,447.95
EPS (Annual)
-$0.4388
P/B
0.86
Rev/Employee
$133,785.71
$15.24
Loading...
Loading...

About

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28

Frequently Asked Questions

What is Market Cap of Scynexis Inc?
What is the 52-week high for Scynexis Inc?
What is the 52-week low for Scynexis Inc?
What is Scynexis Inc stock price today?
What was Scynexis Inc stock price yesterday?
What is the PE ratio of Scynexis Inc?
What is the Price-to-Book ratio of Scynexis Inc?
What is the 50-day moving average of Scynexis Inc?
How many employees does Scynexis Inc have?

Latest SCYX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.